GLP-1 medications mimic this natural hormone and primarily work by: Suppressing appetite and reducing hunger signals Slowing gastric emptying , which promotes fullness Improving insulin response after meals By influencing these pathways, GLP-1 receptor agonists help patients eat less comfortably and improve metabolic efficiency over time
Both effects were statistically significant
Morris V, Janku F, Huang H, Fu S, Overman M, Piha-Paul S, Subbiah V, Kee B, Tsimbierdou A, Fogelman D, Shurieqi I, Manuel S, Scamardo A, Lanman R, Sommer N, Hong D, Kopetz S
Retatrutide is structurally derived from the glucagon peptide family and engineered to activate three related class B GPCR receptors involved in metabolic signaling: the GLP 1 receptor, the GIP receptor, and the glucagon receptor